BUZZ-Edward Lifesciences rises after quarterly results beat estimates** Shares of medical device maker Edwards Lifesciences EW.N rise about 2% to $85.01
** Co beats third-quarter estimates, helped by strong demand for its artificial heart valves and other medical devices
** Edwards reports profit of 67 cents per share, topping expectations of 59 cents per share- data compiled by LSEG
** It reports revenue of $1.55 billion vs. estimates of $1.50 billion
** Co also raises its full-year profit forecast
** Co also says CFO Scott Ullem will step down by mid-2026
** Up to last close, stock 12.7% higher YTD
(Reporting by Anshi Sancheti in Bengaluru)
((Anshi.Sancheti@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.